Our team is led by recognized healthcare, cannabis regulatory and technology leaders/innovators.
Their focus is always on driving to (and measuring) the real-world outcomes that matter most to you - and to all who are working to help cannabis find its place as a responsibly provided, evidence-based medical treatment.
All the input and feedback you provide is securely analyzed by our proprietary data model which then generates draft care plans and insights for our clinicians to review, edit, add to and approve.
This allows them to provide care that’s more informed by more patients like you, spend less time on administrative tasks and more time with you.
Our recommended CBD and THC products are sourced from leading Massachusetts wholesale and delivery partners and must meet our clinical teams’ consistency and efficacy requirements.
A pioneering palliative care clinician and researcher, Dr. Worster is currently Director, Supportive Oncology at Jefferson Health in Philadelphia. She is a graduate of Temple University School of Medicine and completed her fellowship in palliative care and pain management at MGH Brigham and Dana Farber Cancer Center in Boston.
An internationally recognized cannabis clinician and educator, Dr. Caplan has overseen the care of over 18,000 cannabis patients and developed protocols that have benefited tens of thousands more. He is a graduate of Tufts University School of Medicine and completed his residency in family medicine at Boston Medical Center.
A leading clinical geriatric pharmacist and educator, Dr. Hajjar serves as Professor and Director of the Population Health Pharmacy Program at the Jefferson College of Pharmacy. She received her PharmD at Duquesne University and completed a fellowship in Geriatric Pharmacoepidemiology at the University of Minnesota.
Get special offers, event invites and the latest on new care offerings and product releases.